{"schema_version":"secwatch.filing_event.v1","accession":"0001412408-22-000066","form_type":"8-K","ticker":"PHR","cik":"0001412408","company_name":"Phreesia, Inc.","filed_at":"2022-12-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.524175+00:00","generated_at":"2026-06-21T07:25:37.942636+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Phreesia Q3 revenue $73.1M (+31% YoY); raises FY2023 outlook to at least $278M","bullets":["Revenue $73.1M (+31% YoY); net loss $40.2M; Adjusted EBITDA -$18.3M.","Average healthcare services clients 2,982 (+42% YoY); ARPU $17,645 (-9% YoY).","Raises FY2023 revenue outlook to at least $278M; Adjusted EBITDA outlook improved to ~$95M.","Renames 'Life sciences' revenue to 'Network solutions'; introduces MemberConnect for payers.","Estimated TAM expanded to ~$10B from ~$9B due to MemberConnect opportunity."],"urls":{"canonical":"https://secwatch.observer/filing/0001412408-22-000066","json":"https://secwatch.observer/filing/0001412408-22-000066.json","markdown":"https://secwatch.observer/filing/0001412408-22-000066.md","text":"https://secwatch.observer/filing/0001412408-22-000066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1412408/000141240822000066/0001412408-22-000066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1412408/000141240822000066/phr-20221208.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T07:25:37.942636+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8a8ca7a3f05496eb9a31523b42d37eaa4edb98a4","claim":"Phreesia, Inc. reported the fiscal quarter ended October 31, 2022 results: revenue $73.1 million, net income $40.2 million. Guidance raised.","evidence_excerpt":"Revenue was $73.1 million in the quarter as compared to $55.9 million in the same period in the prior year, an increase of 31%.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1412408/000141240822000066/0001412408-22-000066-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter ended October 31, 2022"},{"label":"Revenue","value":"$73.1 million"},{"label":"Net income","value":"$40.2 million"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}